UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Radnor Capital Management LLC

Radnor Capital Management LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,344 shares of the healthcare conglomerate’s stock after selling 230 shares during the period. Radnor Capital Management LLC’s holdings in UnitedHealth Group were worth $2,197,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of UNH. State Street Corp boosted its holdings in shares of UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC boosted its holdings in UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after purchasing an additional 318,039 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares in the last quarter. International Assets Investment Management LLC boosted its stake in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after acquiring an additional 21,149 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.5 %

NYSE UNH opened at $543.76 on Wednesday. The company has a 50-day moving average of $554.45 and a 200-day moving average of $563.12. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market cap of $500.41 billion, a P/E ratio of 35.42, a P/E/G ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the company earned $6.56 EPS. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.54%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on UNH. TD Cowen increased their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. KeyCorp initiated coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Finally, Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.